Drug Type Monoclonal antibody |
Synonyms PTH 0300, PTH0300 |
Target |
Action modulators |
Mechanism IL-25 modulators(interleukin 25 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 1 | United States | 01 Jul 2025 | |
| Dermatitis, Atopic | IND Approval | United States | 01 Jul 2025 | |
| Dermatitis, Atopic | IND Approval | China | 01 Jul 2025 | |
| Idiopathic Pulmonary Fibrosis | IND Application | United States | 01 Jul 2025 | |
| Pulmonary Disease, Chronic Obstructive | IND Application | United States | 01 Jul 2025 |






